Latest filing published 03 Jul 2019 for Calliditas Therapeutics AB, €2.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Bengt julander: trading record in brief
Bengt julander appears in our data through filings on Calliditas Therapeutics AB shares, published by Finansinspektionen. Over a trading history stretching from 29 June 2018 to 3 July 2019, the count stands at 2 filings.
In open-market terms, that means 1 purchase worth €2.9M on one side and 1 sale worth €2.5M on the other. Purchases outweigh sales by €358k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2019 to date brings no purchases and 1 sale.
On 3 July 2019 came the latest disclosure, an open-market sale for €2.5M in Calliditas Therapeutics AB. The clock since the last published purchase (30 June 2018) now reads 3,054 days. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bengt julander
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 440,163 shares@ SEK 60.00100.0% of flowAktieISIN SE0010441584FI:csv-033a5565a02db8d1a7ee
- 666,666 shares@ SEK 45.00100.0% of flowISIN SE0010441584FI:csv-22dc5ff780ec74bb9faaCanonical exit: 27 Sept 2018 (T+90)
2 of 2 declarations